MISGAV, Israel--(BUSINESS WIRE)--The Board of Medgenics (AIM:MEDG) (AIM:MEDU) (‘Medgenics’ or the ‘Company’) announces proposals to facilitate a proposed fundraising through the issue of convertible debentures.
MISGAV, Israel--(BUSINESS WIRE)--The Board of Medgenics (AIM:MEDG) (AIM:MEDU) (‘Medgenics’ or the ‘Company’) announces proposals to facilitate a proposed fundraising through the issue of convertible debentures.
